Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • Rare Disease

Tag: Rare Disease

Infilbray FDA approval venglustat type 3 Gaucher disease infographic
  • Pharmaceuticals

Infilbray FDA Approval: Sanofi Pill Is First to Treat Brain Symptoms of Type 3 Gaucher Disease

Megan Wood4 days ago010 mins

The FDA approved Sanofi’s Infilbray (venglustat), the first drug for neurological symptoms of type 3 Gaucher disease, after it beat enzyme therapy in the LEAP2MONO trial.

Read More
AnnJi AJ201 Phase 3 ROMA-KD Kennedy disease trial featured graphic
  • Pharmaceuticals

AnnJi Advances AJ201 into Phase 3 Trial for Kennedy’s Disease

Megan Wood2 months ago1 month ago011 mins

AJ201 (rosolutamide) moves into the pivotal Phase 3 ROMA-KD trial for Kennedy disease, or SBMA. Mechanism, earlier data and what is unknown.

Read More

Categories

  • Healthcare IT (26)
  • Industry Insights (370)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (116)
  • Uncategorized (1)

Recent Posts

  • Roundup Settlement Approved: How Bayer’s $7.25B Cancer Deal Pays Out
  • Novo Nordisk Layoffs: 215 More Jobs Cut at US Headquarters in Sales Overhaul
  • MAHA ELEVATE Model: CMS Awards $47M to 15 Groups to Test Lifestyle Medicine in Medicare
  • Rasonque EU Approval: Daraxonrasib Becomes Europe’s First RAS Pill for Pancreatic Cancer
  • Barzolvolimab Atopic Dermatitis Trial Fails: Celldex Drops Eczema to Focus on Hives
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.